Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › APE/REF1 inhibitors for the treatment of cancer

APE/REF1 inhibitors for the treatment of cancer

US Patent 12128015 · Granted Oct 29, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

SK channel positive allosteric modulators2025
Use of neuronal nitric oxide synthase inhibitors for immunotherapy in melanoma p2024
Targeted peptide-drug conjugates2024
Use of neuronal nitric oxide synthase inhibitors for immunotherapy in melanoma p2022
pH-sensitive cyclic peptides2022
Methods for skin whitening using a gallotannin2018
Topical pterostilbene compositions for use in treating UV-induced loss of barrie2018
Carcinoma diagnosis and treatment, based on ODC1 genotype2018
Substituted nucleoside derivatives with antiviral and antimicrobial properties2017
Substituted nucleoside derivatives with antiviral and antimicrobial properties2016
Carcinoma diagnosis and treatment, based on ODC1 genotype2015
Specific nNOS inhibitors for the therapy and prevention of human melanoma2015